China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro®
03 févr. 2024 20h00 HE
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, Feb. 03, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 2 February 2024, the Group through its wholly-owned...
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
02 janv. 2024 01h33 HE
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- On 29 December, 2023, PharmaGend Global Medical Services Pte. Ltd. (“PharmaGend”), jointly invested by China Medical System Holdings Limited...
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL
13 déc. 2023 03h13 HE
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Innovative drugs VALTOCO (Diazepam Nasal Spray)，ILUMETRI (Tildrakizumab Injection) and rare disease drug Tetrabenazine Tablets have been newly...
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
04 déc. 2023 08h28 HE
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The New Drug Application for an additional rheumatoid arthritis (RA) indication of Methotrexate Injection has been accepted by NMPA, which is a new...
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
24 août 2023 08h00 HE
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Y-3, a Class 1 Innovative Drug injection, is used to alleviate neurological symptoms and dysfunction of daily activities caused by acute ischemic...
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management
31 juil. 2023 08h00 HE
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, July 31, 2023 (GLOBE NEWSWIRE) -- Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and...
China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global
29 juin 2023 08h00 HE
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, June 29, 2023 (GLOBE NEWSWIRE) -- CMS was included into the first “Sustainability Yearbook (China)” published by S&P Global. Nearly 1600 Chinese companies were included in the...
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China
12 juin 2023 08h00 HE
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, June 12, 2023 (GLOBE NEWSWIRE) -- CMS is pleased to announce the NDA of the first Diazepam Nasal Spray has been approved for marketing in China. The Product can meet current...
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China
30 mai 2023 10h30 HE
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, May 30, 2023 (GLOBE NEWSWIRE) -- CMS is pleased to announce the NDA of Tildrakizumab Injection under the brand name of ILUMETRI, a monoclonal antibody specifically targeting the p19...
NOTICE TO DISREGARD -- China Medical System Holdings Ltd.
21 déc. 2022 06h08 HE
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, Dec. 21, 2022 (GLOBE NEWSWIRE) -- We are advised by China Medical System Holdings Ltd. that journalists and other readers should disregard the news release, "CMS (867.HK) Joins Hand...